av/sorrento-therapeutics--big.svg

NASDAQ:SRNE

Sorrento Therapeutics, Inc.

  • Stock

USD

Last Close

0.01

25/09 13:30

Market Cap

6.06M

Beta: -

Volume Today

1.15K

Avg: 36.50M

PE Ratio

−0.25

PFCF: −0.62

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
revenue
460.15K
-
3.83M
731.25%
4.59M
20%
8.15M
77.60%
151.86M
1,762.81%
21.19M
86.04%
31.43M
48.31%
39.99M
27.21%
52.90M
32.31%
62.84M
18.78%
cost of revenue
4.44K
-
2.04M
45,913.51%
1.95M
4.55%
811K
58.41%
3.94M
386.44%
7.06M
78.96%
12.24M
73.33%
9.94M
18.77%
13.03M
31.10%
33.45M
156.71%
gross profit
455.71K
-
1.78M
291.04%
2.64M
48.15%
7.34M
178.07%
147.91M
1,914.86%
14.13M
90.44%
19.20M
35.82%
30.05M
56.53%
39.87M
32.71%
29.39M
26.30%
selling and marketing expenses
general and administrative expenses
6.32M
-
9.99M
58.09%
20.13M
101.58%
24.22M
20.30%
38.33M
58.27%
63.64M
66.02%
selling general and administrative expenses
6.32M
-
9.99M
58.09%
20.13M
101.58%
24.22M
20.30%
38.33M
58.27%
63.64M
66.02%
103.56M
62.73%
116.18M
12.19%
196.86M
69.44%
182.34M
7.38%
research and development expenses
9.02M
-
23.98M
165.99%
31.34M
30.69%
42.17M
34.56%
55.53M
31.67%
76.96M
38.59%
106.88M
38.87%
111.34M
4.17%
206.92M
85.85%
221.23M
6.91%
other expenses
804.07K
-
2.35M
191.64%
1.16M
50.66%
845K
26.97%
2.61M
208.88%
3.01M
15.29%
3.94M
30.97%
4.05M
2.84%
4.14M
2.15%
4.33M
4.47%
cost and expenses
16.14M
-
38.36M
137.62%
54.58M
42.30%
68.05M
24.67%
100.42M
47.57%
150.67M
50.04%
226.61M
50.40%
241.51M
6.57%
420.95M
74.30%
441.34M
4.84%
operating expenses
16.14M
-
36.31M
125.03%
52.63M
44.93%
67.24M
27.75%
96.47M
43.48%
143.61M
48.86%
214.38M
49.28%
231.57M
8.02%
407.92M
76.15%
407.89M
0.01%
interest expense
253.19K
-
1.63M
543.38%
1.65M
1.41%
1.61M
2.54%
4.98M
209.32%
57.63M
1,057.25%
36.14M
37.29%
20.18M
44.16%
10.22M
49.34%
8.57M
16.14%
ebitda
-20.37M
-
-31.55M
54.88%
-5.47M
82.64%
-57.32M
947.01%
-14.85M
74.10%
-143.13M
864.03%
-183.10M
27.93%
-191.87M
4.79%
-383.45M
99.85%
-364.52M
4.94%
operating income
-21.67M
-
-34.74M
60.34%
-74.00M
113.01%
-96.78M
30.77%
25.34M
126.18%
-150.43M
693.74%
-195.18M
29.75%
-201.53M
3.25%
-368.05M
82.63%
-378.50M
2.84%
depreciation and amortization
1.29M
-
3.18M
146.74%
2.37M
25.57%
2.88M
21.73%
7.08M
145.37%
9.05M
27.90%
12.08M
33.42%
9.65M
20.09%
-15.41M
259.64%
13.98M
190.73%
total other income expenses net
-243.58K
-
-1.62M
563.85%
60.24M
3,825.73%
31.94M
46.98%
-10.02M
131.37%
-63.36M
532.30%
-164.39M
159.48%
-109.05M
33.66%
-94.48M
13.36%
-183.25M
93.95%
income before tax
-21.91M
-
-36.36M
65.94%
-13.76M
62.16%
-64.83M
371.17%
15.31M
123.62%
-213.78M
1,495.89%
-359.58M
68.20%
-310.58M
13.63%
-462.53M
48.92%
-561.75M
21.45%
income tax expense
9.62K
-
-1.70M
17,801.51%
36.31M
2,233.61%
-896K
102.47%
-36.04M
3,922.10%
-6.27M
82.59%
-473K
92.46%
-2.01M
325.79%
-33.52M
1,564.15%
-2.42M
92.79%
net income
-21.91M
-
-34.66M
58.17%
-45.81M
32.18%
-60.92M
32.99%
9.13M
114.99%
-203.54M
2,328.87%
-359.10M
76.43%
-308.57M
14.07%
-429.01M
39.03%
-559.33M
30.38%
weighted average shs out
15.05M
-
26.68M
77.32%
36.91M
38.34%
50.36M
36.44%
69.74M
38.49%
106.15M
52.20%
140.51M
32.37%
229.82M
63.56%
294.77M
28.26%
419.31M
42.25%
weighted average shs out dil
15.05M
-
26.68M
77.32%
36.91M
38.34%
50.36M
36.44%
70.38M
39.76%
106.15M
50.82%
140.51M
32.37%
229.82M
63.56%
294.77M
28.26%
419.31M
42.25%
eps
-1.46
-
-1.30
10.96%
-1.24
4.62%
-1.21
2.42%
0.13
110.74%
-1.92
1,576.92%
-2.56
33.33%
-1.34
47.66%
-1.46
8.96%
-1.33
8.90%
epsdiluted
-1.46
-
-1.30
10.96%
-1.24
4.62%
-1.21
2.42%
0.13
110.74%
-1.92
1,576.92%
-2.56
33.33%
-1.34
47.66%
-1.46
8.96%
-1.33
8.90%

All numbers in USD (except ratios and percentages)